Attached files

file filename
8-K - 8K BODY - STERICYCLE INCbo8k0613.htm



EXHIBIT 99.1



FOR FURTHER INFORMATION CONTACT:

FOR IMMEDIATE RELEASE

Frank ten Brink  847-607-2012

 

Conference call to be held July 24, 2013 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through August 24th by dialing 855-859-2056, access code 86466843. To hear a live simulcast of the call over the internet on www.earnings.com, or to access an audio archive of the call, go to the Investors page on Stericycle’s website at www.stericycle.com.




STERICYCLE, INC. REPORTS RESULTS

FOR THE SECOND QUARTER AND YEAR TO DATE 2013


Lake Forest, Illinois, July 24, 2013—Stericycle, Inc. (NASDAQ:SRCL), today reported financial results for the second quarter of 2013.



SECOND QUARTER RESULTS

Revenues for the quarter ended June 30, 2013 were $526.5 million, up $57.6 million or 12.3% from $468.9 million in the second quarter last year.  Acquisitions contributed approximately $34.1 million to the current period’s growth in revenues.  Revenues increased 13.1% compared to the prior period when adjusted for unfavorable foreign exchange impact of $4.1 million.  Gross profit was $237.9 million, up 13.5% from $209.5 million in the second quarter last year.  Gross profit as a percent of revenue was 45.2% compared with 44.7% in the second quarter of 2012.  Earnings per diluted share, reported in accordance with U.S. generally accepted accounting principles (“GAAP”), increased 14.4% to $0.89 from $0.78 in the second quarter last year. Non-GAAP earnings per diluted share, when adjusted for various items identified in the second of the following tables, increased 14.2% to $0.93 from $0.81.  See tables below.




FIRST SIX MONTHS’ RESULTS

Revenues for the six months ending June 30, 2013 were $1,040.3 million, up $111.3 million or 12.0% from $929.0 million in the same period last year. Revenues increased 12.9% compared with the prior period when adjusted for unfavorable foreign exchange impact of $8.3 million.  Gross profit was $469.9 million, up 13.3% from $414.8 million in the same period last year.  Gross profit as a percent of revenue was 45.2% compared with 44.6% in 2012.  GAAP earnings per diluted share increased 14.2% to $1.74 from $1.53 in the same period last year.  Non-GAAP earnings per diluted share, when adjusted for various items identified in the second of the following tables, increased 12.8% to $1.81 from $1.60.  See tables below.



The following table shows our calculations of organic revenue growth (in millions)(1):

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

Change

 

 

 

Change

 

2013

2012

$

%

 

2013

2012

$

%

Total As Reported Revenues (GAAP)

 $   526.5

 $       468.9

     $      57.6

12.3%

 

 $ 1,040.3

 $     929.0

  $         111.3

12.0%

Adjustment for Foreign Exchange

         4.1

              -   

            4.1

 

 

          8.3

             -   

               8.3

 

Subtotal (non-GAAP):

     530.6

         468.9

          61.7

13.1%

 

   1,048.6

        929.0

           119.6

12.9%

 

 

 

 

 

 

 

 

 

 

Adjustment for Acquisitions

      (37.7)

            (3.6)

          (34.1)

 

 

       (75.3)

           (4.2)

            (71.1)

 

Adjustment for Regulated Returns and

Recall Management Services

      (23.7)

          (29.0)

            5.3

 

 

       (46.3)

         (64.7)

             18.4

 

Subtotal (non-GAAP):

 $  469.2

 $      436.3

 $       32.9

7.5%

 

 $   927.0

 $     860.1

 $          66.9

7.8%

 

 

 

 

 

 

 

 

 

 

Domestic/ International Breakdown:

 

 

 

 

 

 

 

 

 

Domestic Revenues

 $   370.2

 $       337.8

 $        32.4

9.6%

 

 $    733.8

 $     667.0

 $          66.8

10.0%

International Revenues

     156.3

         131.1

           25.2

19.2%

 

      306.5

        262.0

             44.5

17.0%

Total As Reported Revenues (GAAP)

 $   526.5

 $       468.9

 $        57.6

12.3%

 

 $ 1,040.3

 $     929.0

 $         111.3

12.0%


(1) For internal purposes, we exclude the impact of foreign exchange and revenues attributed to acquisitions closed within the preceding 12 months and from our regulated returns and recall management services when we evaluate organic revenue growth. This table and the Company’s internal use of non-GAAP adjusted revenues are not intended to imply, and should not be interpreted as implying, that non-GAAP adjusted revenues are a better measure of internal growth or the Company’s performance, as compared to GAAP revenues.



Table to reconcile GAAP EPS to Non-GAAP EPS(2):

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

Change

 

 

 

Change

 

2013

2012

$

%

 

2013

2012

$

%

GAAP EPS

 $    0.89

 $    0.78

 $    0.11

14.4%

 

 $    1.74

 $    1.53

 $    0.22

14.2%

 

 

 

 

 

 

 

 

 

 

Acquisition Expenses

       0.03

       0.03

 

 

 

       0.05

       0.04

 

 

Integration Expenses

       0.01

       0.01

 

 

 

       0.02

       0.02

 

 

Change in Fair Value

     (0.00)

     (0.01)

 

 

 

     (0.00)

       0.01

 

 

Restructuring and Plant Closure

       0.00

       0.01

 

 

 

       0.00

       0.01

 

 

Litigation Settlement

     (0.00)

          -

 

 

 

       0.00

          -

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP EPS (Adjusted)

 $    0.93

 $    0.81

 $    0.11

14.2%

 

 $    1.81

 $    1.60

 $    0.21

12.8%

 


(2) In accordance with GAAP, reported earnings per share (EPS) include the after-tax impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance. This table and the Company’s internal use of non-GAAP earnings per share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per share is a better measure of performance than GAAP earnings per share.


Cash flow from operations was $176.5 million and $188.8 million for the six months ended June 30, 2013 and 2012, respectively.


For more information about Stericycle, please visit our website at www.stericycle.com.








Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.








STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS)

(UNAUDITED)

 

 

 

 

June 30,

December 31,

 

2013

2012

ASSETS

 

 

Current Assets:

 

 

Cash and cash equivalents

 $               18,001

 $                   31,324

Short-term investments

                        460

                           503

Accounts receivable, net

                361,894

                    322,246

Deferred income taxes

                   19,998

                      22,995

Prepaid expenses

                   27,691

                      27,042

Other current assets

                   39,721

                      37,176

        Total Current Assets

                467,765

                    441,286

Property, plant and equipment, net

                345,743

                    335,870

Goodwill

             2,094,459

                 2,065,103

Intangible assets, net

                673,222

                    667,471

Other assets

                   37,236

                      37,008

       Total Assets

 $          3,618,425

 $              3,546,738

 

 

 

LIABILITIES AND EQUITY

 

 

Current Liabilities:

 

 

Current portion of long-term debt

 $               72,430

 $                   87,781

Accounts payable

                   88,420

                      74,225

Accrued liabilities

                122,430

                    135,321

Deferred revenues

                   18,183

                      18,095

Other current liabilities

                   12,497

                      15,638

      Total Current Liabilities

                313,960

                    331,060

Long-term debt, net of current portion

             1,246,203

                 1,268,303

Deferred income taxes

                371,467

                    359,780

Other liabilities

                   37,352

                      30,272

Equity:

 

 

Common stock

                        859

                           860

Additional paid-in capital

                159,961

                    116,720

Accumulated other comprehensive loss

                 (78,564)

                    (39,064)

Retained earnings

             1,549,769

                 1,463,277

  Total Stericycle, Inc. Equity

             1,632,025

                 1,541,793

Noncontrolling interests

                   17,418

                      15,530

  Total Equity

             1,649,443

                 1,557,323

       Total Liabilities and Equity

 $          3,618,425

 $              3,546,738














STERICYCLE, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(IN THOUSANDS EXCEPT SHARES AND PER SHARE DATA)

(UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

Six Months Ended

 

 

June 30,

 

 

 

June 30,

 

 

2013

 

 

2012

 

 

 

2013

 

 

2012

 

 

$

% of Rev

 

 

$

% of Rev

 

 

 

$

% of Rev

 

 

$

% of Rev

Revenues

$

526,525

100.0

 

$

468,950

100.0

 

 

$

1,040,329

100.0

 

$

929,027

100.0

Cost of revenues (exclusive of depreciation shown below)

 

276,385

52.5

 

 

248,832

53.1

 

 

 

546,058

52.5

 

 

493,014

53.1

Depreciation - cost of revenues

 

12,288

2.3

 

 

10,630

2.3

 

 

 

24,325

2.3

 

 

21,218

2.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

237,852

45.2

 

 

209,488

44.7

 

 

 

469,946

45.2

 

 

414,795

44.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses (exclusive of depreciation and amortization below)

 

91,158

17.3

 

 

80,652

17.2

 

 

 

179,399

17.2

 

 

158,459

17.1

Depreciation - SG&A

 

2,954

0.6

 

 

2,261

0.5

 

 

 

5,763

0.6

 

 

 4,412

0.5

Amortization

 

6,533

1.2

 

 

5,135

1.1

 

 

 

13,175

1.3

 

 

10,114

1.1

Total SG&A expense and amortization

 

100,645

19.1

 

 

88,048

18.8

 

 

 

198,337

19.1

 

 

172,985

18.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations before acquisition, integration, and other expenses

 

137,207

26.1

 

 

121,440

25.9

 

 

 

271,609

26.1

 

 

241,810

26.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition expenses

 

2,324

0.4

 

 

2,207

0.5

 

 

 

4,127

0.4

 

 

3,746

0.4

Integration expenses

 

1,383

0.3

 

 

1,044

0.2

 

 

 

2,279

0.2

 

 

2,323

0.3

Change in fair value of contingent consideration

 

(122)

0.0

 

 

(602)

-0.1

 

 

 

 (122)

0.0

 

 

 602

0.1

Litigation settlement

 

(2)

0.0

 

 

 -

0.0

 

 

 

104

0.0

 

 

 -

0.0

Restructuring and plant closure costs

 

104

0.0

 

 

1,064

0.2

 

 

 

104

0.0

 

 

1,150

0.1

Income from operations

 

133,520

25.4

 

 

117,727

25.1

 

 

 

 265,117

25.5

 

 

233,989

25.2

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

102

0.0

 

 

124

0.0

 

 

 

 269

0.0

 

 

216

0.0

Interest expense

 

(13,015)

-2.5

 

 

(12,783)

-2.7

 

 

 

(26,561)

-2.6

 

 

(25,549)

-2.8

Other expense, net

 

(545)

-0.1

 

 

490

0.1

 

 

 

(1,558)

-0.1

 

 

(68)

0.0

    Total other expense

 

(13,458)

-2.6

 

 

(12,169)

-2.6

 

 

 

(27,850)

-2.7

 

 

 (25,401)

-2.7

Income before income taxes

 

120,062

22.8

 

 

105,558

22.5

 

 

 

237,267

22.8

 

 

208,588

22.5

Income tax expense

 

41,619

7.9

 

 

37,186

7.9

 

 

 

83,602

8.0

 

 

74,901

8.1

Net income

 

78,443

14.9

 

 

 68,372

14.6

 

 

 

153,665

14.8

 

 

133,687

14.4

Less: net income attributable to noncontrolling interests

 

399

0.1

 

 

779

0.2

 

 

 

1,004

0.1

 

 

1,237

0.1

Net income attributable to Stericycle, Inc.

$

78,044

14.8

 

$

 67,593

14.4

 

 

$

152,661

14.7

 

$

132,450

14.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share - diluted

$

0.89

 

 

$

0.78

 

 

 

$

1.74

 

 

$

1.53

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding - diluted

 

87,614,953

 

 

 

86,835,615

 

 

 

 

87,545,641

 

 

 

86,714,407

 









STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

(UNAUDITED)

 

 

 

 

 

 

 

 

Six Months Ended

 

 

June 30,

 

 

2013

 

 

2012

Operating Activities:

 

 

 

 

 

Net income

$

             153,665

 

$

          133,687

Adjustments to reconcile net income to net cash

 

 

 

 

 

   provided by operating activities:

 

 

 

 

 

Change in fair value of contingent consideration

 

                  (122)

 

 

                602

Stock compensation expense

 

                 7,943

 

 

             8,217

Excess tax benefit of stock options exercised

 

                (8,373)

 

 

          (11,523)

Depreciation

 

               30,088

 

 

           25,630

Amortization

 

               13,175

 

 

           10,114

Deferred income taxes

 

               13,101

 

 

           14,546

Changes in operating assets and liabilities, net of

 

 

 

 

 

  effect of acquisitions and divestitures:

 

 

 

 

 

Accounts receivable

 

              (42,871)

 

 

             5,368

Accounts payable

 

                 9,619

 

 

             7,252

Accrued liabilities

 

                (2,231)

 

 

            (6,409)

Deferred revenue

 

                  (548)

 

 

             2,111

Other assets and liabilities

 

                 3,037

 

 

               (797)

 

 

 

 

 

 

Net cash provided by operating activities

 

             176,483

 

 

          188,798

 

 

 

 

 

 

Investing Activities:

 

 

 

 

 

Payments for acquisitions, net of cash acquired

 

              (63,401)

 

 

         (111,716)

Proceeds from/ (purchases of) short-term investments

 

                     33

 

 

                  (2)

Capital expenditures

 

              (37,441)

 

 

          (33,819)

 

 

 

 

 

 

Net cash used in investing activities

 

            (100,809)

 

 

         (145,537)

 

 

 

 

 

 

Financing Activities:

 

 

 

 

 

Net repayment of long-term debt

 

              (35,795)

 

 

          (38,323)

Net repayments on senior credit facility

 

              (16,714)

 

 

          (10,074)

Payments of deferred financing costs

 

                      -

 

 

               (148)

Payments on capital lease obligations

 

                (1,825)

 

 

            (1,278)

Purchase and cancellation of treasury stock

 

              (66,175)

 

 

            (2,945)

Payments to noncontrolling interests

 

                      -

 

 

                 (10)

Proceeds from other issuances of common stock

 

               23,667

 

 

           28,450

Excess tax benefit of stock options exercised

 

                 8,373

 

 

           11,523

 

 

 

 

 

 

Net cash used in financing activities

 

              (88,469)

 

 

          (12,805)

Effect of exchange rate changes on cash

 

                  (528)

 

 

             1,246

Net (decrease)/ increase in cash and cash equivalents

 

              (13,323)

 

 

           31,702

Cash and cash equivalents at beginning of period

 

               31,324

 

 

           22,511

 

 

 

 

 

 

Cash and cash equivalents at end of period

$

               18,001

 

$

           54,213

 

 

 

 

 

 

Non-cash activities:

 

 

 

 

 

Net issuances of obligations for acquisitions

$

               22,906

 

$

           34,328